The Coronavirus pandemic continues to sweep across the globe. It is causing a lot of stress, fear, and uncertainty to people, especially to the care providers, older adults, and those who are already living with underlying health conditions. The global lockdown has greatly affected routines, activities, and livelihoods, leading to a surge in the number … Continue reading Looking after your mental health during COVID-19 pandemic
Early Insulinization Can be Key to Effective Diabetes Management
Diabetes is a global epidemic and the number of people with diabetes globally is growing at an alarming rate. An estimated 463 million adults (20-79 years), or about 1 in 11 adults worldwide, are living with diabetes across the world in 2019; by 2045 this will rise to 700 million1. Globally, the number of people … Continue reading Early Insulinization Can be Key to Effective Diabetes Management
A Disease of Halves: Why better patient adherence to treatment is important to manage diabetes?
Diabetes Mellitus is a major health issue with nearly half a billion people living with this ailment globally. Diabetes is a serious, chronic or long-term condition that occurs when there are elevated levels of glucose in a person’s blood because their body cannot produce any or enough of the hormone insulin, or cannot effectively use … Continue reading A Disease of Halves: Why better patient adherence to treatment is important to manage diabetes?
Dialysis in India – Today and Tomorrow
Professor Vivekanand Jha shares his views on how Dialysis is one of the first technological innovations in medicine and why we need to leverage this technology to address the huge kidney failure burden our country faces.
Rare Diseases – A Huge Unmet Need in Diagnosis, Treatment and Management
A Disease may be Rare but Hope should not be!
‘KRABEVA®’s Unique ‘Qual-Check’ Mechanism Ensures Patients Get a Quality-Ascertained Product’: Suresh Subramanian
Mr. Suresh Subramanian, Senior Vice President & Head Branded Formulations, Biocon shares his views on how KRABEVA® can make a significant impact in the biosimilars space.
